Anticipation in families with MLH1 ‐associated Lynch syndrome
Cancer · 2025
DOI: 10.1002/cncr.35589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2025. Verfasst von Arti S Pandey und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Genetic Counseling, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, MutL Protein Homolog 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Lynch syndrome (LS) is an autosomal‐dominant, hereditary cancer predisposition syndrome caused by pathogenic variants (PVs) in one of the mismatch‐repair genes MLH1 , MSH2/EPCAM , MSH6 , or PMS2 . Individuals who have MLH1 PVs have high lifetime risks of colorectal cancer (CRC) and endometrial cancer (EC). There is controversy regarding whether a younger age at diagnosis (or anticipation) occurs in MLH1 ‐associated LS. The objective of this study was to assess anticipation in families with MLH1‐ associated LS by using statistical models while controlling for potential confounders.
Methods
Data from 31 families with MLH1 PVs were obtained from an academic registry. Wilcoxon signed‐rank tests on parent–child‐pairs as well as parametric Weibull and semiparametric Cox proportional hazards and Cox mixed‐effects models were used to calculate hazard ratios or to compare mean ages at CRC/EC diagnosis by generation. Models were also corrected for ascertainment bias and birth‐cohort effects.
Results
A trend toward younger ages at diagnosis of CRC/EC in successive generations, ranging from 3.2 to 15.7 years, was observed in MLH1 PV carrier families. A greater hazard for cancer in younger generations was not precluded by the inclusion of birth cohorts in the model. Individuals who had MLH1 variants with no Mlh1 activity were at a 78% greater hazard for CRC/EC than those who retained Mlh1 activity.
Conclusions
The current results demonstrated evidence in support of anticipation in families with MLH1‐ associated LS across all statistical models. Mutational effects on Mlh1 activity influenced the hazard for CRC/EC. Screening based on the youngest age of cancer diagnosis in MLH1‐LS families is recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Genetic Counseling, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Division of Cancer Predisposition, Oncology, St Jude Children's Hospital, Memphis, Tennessee, USA.
- Section of Gastroenterology, Hepatology and Nutrition, Department of Medicine, The University of Chicago, Chicago, Illinois, USA.
- Public Health Sciences, The University of Chicago, Chicago, Illinois, USA.
- Clinical Service Liaison Operations, GeneDx, Crystal Lake, Illinois, USA.
- Helix, San Mateo, California, USA.
ORCID-Profile: Arti S Pandey
Förderung
- NCI NIH HHS
Zitieren
APA
Pandey, A. S., Drogan, C., Huo, D., Postula, K., Garg, S. M., & Kupfer, S. S. (2025). Anticipation in families with MLH1 ‐associated Lynch syndrome. Cancer. https://doi.org/10.1002/cncr.35589
Vancouver
Pandey AS, Drogan C, Huo D, Postula K, Garg SM, Kupfer SS. Anticipation in families with MLH1 ‐associated Lynch syndrome. Cancer. 2025. doi:10.1002/cncr.35589
BibTeX
@article{Pandey2025,
author = {Pandey, Arti S and Drogan, Christine and Huo, Dezheng and Postula, Kristen and Garg, Shreshtha M and Kupfer, Sonia S},
title = {Anticipation in families with MLH1 ‐associated Lynch syndrome},
journal = {Cancer},
year = {2025},
doi = {10.1002/cncr.35589}
}
EUVIMED